diphenylcyclopropenone has been researched along with Leishmaniasis, Cutaneous in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Layegh, P; Mashayekhi Goyonlo, V; Nahidi, Y; Najaf Najafi, M; Taghavi, F | 1 |
1 trial(s) available for diphenylcyclopropenone and Leishmaniasis, Cutaneous
| Article | Year |
|---|---|
Immunomodulatory effects of topical diphencyprone for the treatment of acute urban cutaneous leishmaniasis.
Topics: Acute Disease; Administration, Topical; Adolescent; Adult; Antiprotozoal Agents; Cyclopropanes; Drug Therapy, Combination; Female; Humans; Immunologic Factors; Leishmaniasis, Cutaneous; Male; Meglumine Antimoniate; Middle Aged; Pilot Projects; Treatment Outcome; Young Adult | 2021 |